Polpharma Biologics is a division of Polpharma Group, one of the largest pharmaceutical companies in central and eastern Europe and one of the top 20 generic drug manufacturers globally. Based in Gdańsk, Poland, Polpharma Biologics produces and markets biosimilar drugs, and offers world-class contract R&D services and cGMP production capabilities to external customers. Polpharma Biologics provides integrated solutions for biopharmaceutical development and the production value chain. A one-stop-shop CDMO, Polpharma Biologics provides a wide range of development and manufacturing services, including cell line development, analytical development, upstream and downstream lab-scale process development, formulation development, pilot manufacturing development and GMP manufacturing.